Lynn M. Schuchter: Dr. Bertagnolli is the ideal leader for NIH and I enthusiastically endorse and urge the Senate to confirm her.
Lynn M. Schuchter shared on Twitter:
“Amazing testimony by Dr. Monica Bertagnolli during yesterday’s Senate confirmation hearing to be NIH Director. Hearing included thoughtful discussion on obesity epidemic, rural healthcare access, inflammation in disease, disparities in care, clinical trial diversity and more.
These are also issues we prioritize at ASCO because everyone deserves access to high quality, affordable and equitable care. Dr. Bertagnolli is the ideal leader for NIH and I enthusiastically endorse and urge the Senate to confirm her.”
Source: Lynn M. Schuchter/Twitter
Lynn M. Schuchter is the President of the American Society of Clinical Oncology (ASCO). Dr. Schuchter is the Chief of the Division of Hematology-Oncology at the Abramson Cancer Center at the University of Pennsylvania, Director of the Tara Miller Melanoma Center and Professor of Hematology-Oncology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Schuchter served on the ASCO Board of Directors from 2009 to 2012, as well as several ASCO committees, including terms as Chair of the Annual Meeting Scientific Program Committee, Cancer Research Committee, and Cancer Communications Committee. In 2019, she was awarded ASCO’s Women Who Conquer Cancer Mentorship Award.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023